Pharmacogenomic analysis of patient-derived tumor cells in gynecologic cancers
Abstract Background Gynecologic malignancy is one of the leading causes of mortality in female adults worldwide.Comprehensive genomic analysis has revealed a list of molecular aberrations that are essential to tumorigenesis, progression, and metastasis of gynecologic tumors.However, targeting such alterations has frequently led to treatment failure